Pui Y Lee Selected Research

Tertiary Lymphoid Structures

4/2013	Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells.
9/2009	Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
4/2009	B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus.
9/2008	Colocalization of antigen-specific B and T cells within ectopic lymphoid tissue following immunization with exogenous antigen.
4/2006	Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pui Y Lee Research Topics

Disease

11	Inflammation (Inflammations) 01/2022 - 01/2009
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 12/2005
5	Tertiary Lymphoid Structures 04/2013 - 04/2006
4	Vasculitis (Vasculitides) 01/2022 - 01/2017
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 01/2019
3	Macrophage Activation Syndrome 01/2022 - 01/2020
3	Arthritis (Polyarthritis) 01/2021 - 01/2019
3	Peritonitis 12/2019 - 11/2009
3	Hemorrhage 01/2019 - 10/2011
3	Proteinuria 06/2013 - 11/2007
3	Glomerulonephritis 04/2012 - 11/2007
3	Nephritis 01/2009 - 11/2007
2	Stroke (Strokes) 01/2022 - 01/2021
2	Lupus Nephritis 10/2020 - 01/2009
2	Autoimmune Diseases (Autoimmune Disease) 07/2015 - 12/2005
1	Lung Diseases (Lung Disease) 01/2022
1	Eosinophilia 01/2022
1	Juvenile gout 01/2022
1	deficiency of adenosine deaminase 2 01/2022
1	Hyperferritinemia 11/2020
1	Thrombocytopenia (Thrombopenia) 11/2020
1	Cytopenia 11/2020
1	Lymphopenia (Lymphocytopenia) 11/2020
1	Pulmonary Alveolar Proteinosis 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Pure Red-Cell Aplasia 01/2020
1	Cytokine Release Syndrome 01/2020
1	Dermatomyositis (Dermatopolymyositis) 01/2020
1	Rheumatoid Arthritis 01/2019
1	Osteoporosis 01/2019
1	Compression Fractures (Compression Fracture) 01/2019
1	Infections 01/2018
1	Obesity 09/2017
1	Insulin Resistance 09/2017
1	Tuberous Sclerosis (Bourneville's Disease) 05/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 07/2015
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 05/2015
1	Sepsis (Septicemia) 08/2011
1	Fatigue 06/2010
1	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2009
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2009

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 10/2020 - 12/2005
11	pristane (pristan)IBA 10/2020 - 12/2008
8	Interferon Type IIBA 08/2011 - 12/2005
4	CytokinesIBA 11/2020 - 08/2011
4	Antigen-Antibody Complex (Immune Complex)IBA 07/2015 - 11/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
3	Adenosine DeaminaseIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2009
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 11/2009
2	AntigensIBA 11/2020 - 09/2008
2	Janus Kinase InhibitorsIBA 01/2020 - 01/2019
2	EnzymesIBA 01/2020 - 05/2015
2	tofacitinibIBA 01/2020 - 01/2019
2	Interleukin-1 (Interleukin 1)IBA 12/2019 - 11/2009
2	LigandsIBA 06/2013 - 12/2005
2	RibonucleoproteinsIBA 12/2008 - 12/2005
2	DNA (Deoxyribonucleic Acid)IBA 12/2008 - 12/2005
1	Pharmaceutical PreparationsIBA 01/2022
1	ProteomeIBA 01/2022
1	Febuxostat FDA Link 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	fibrin fragment D (D-dimer)IBA 11/2020
1	Interleukin-10 (Interleukin 10)IBA 11/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	InterferonsIBA 01/2020
1	IntegrinsIBA 12/2019
1	GlucocorticoidsIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	osteoblast cadherinIBA 09/2017
1	Interleukin-33IBA 09/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2017
1	Immunoglobulin M (IgM)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Complement Receptors (Complement Receptor)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 07/2015
1	ImmunosorbentsIBA 05/2015
1	CollagenIBA 05/2015
1	Toll-Like Receptor 3IBA 06/2013
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2011
1	Myeloid Differentiation Factor 88IBA 10/2011
1	Chemokine CXCL10IBA 08/2011
1	ChemokinesIBA 08/2011
1	AlkanesIBA 02/2011
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 02/2011
1	HydrocarbonsIBA 02/2011
1	Immunoglobulin E (IgE)IBA 11/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 10/2011
2	Intraperitoneal Injections 01/2017 - 10/2011
1	Aftercare (After-Treatment) 01/2020
1	Ligation 12/2019
1	Glycemic Control 09/2017
1	Transplantation 04/2013